Citation:Schaake-Koning C, van den Bogaert W, Dalesio O, Festen J, Hoogenhout J, van Houtte P, et al 1992

From Cancer Guidelines Wiki

Citation


Schaake-Koning C, van den Bogaert W, Dalesio O, Festen J, Hoogenhout J, van Houtte P, et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 1992 Feb 20;326(8):524-30 Available from: http://www.ncbi.nlm.nih.gov/pubmed/1310160.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Schaake-Koning C, van den Bogaert W, Dalesio O, Festen J, Hoogenhout J, van Houtte P, et al 1992What is the optimal chemotherapy regime in concurrent chemo-radiotherapy in inoperable stage III NSCLC?Dr Adelaide Morgancompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:What is the optimal chemotherapy regime in concurrent chemo-radiotherapy in inoperable stage III NSCLC?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the optimal chemotherapy regime in concurrent chemo-radiotherapy in inoperable stage III NSCLC?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. What is the recommended treatment approach for the definitive management of patients with good performance status and inoperable stage III disease?
Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Citation:Schaake-Koning_C,_van_den_Bogaert_W,_Dalesio_O,_Festen_J,_Hoogenhout_J,_van_Houtte_P,_et_al_1992&oldid=20908"